CHEK2 and cancer: Methods This is a retrospective descriptive study including patients diagnosed with urological cancers and testing positive for gPVs in <i>BRCA1</i>, <i>BRCA2</i>, or <i>CHEK2</i>, identified at the Hereditary Cancer Risk Clinic of the Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG).